This is a historical report — it no longer reflects this drug's current status. Current status: Anticipated Shortage. View this drug's full profile page →
MYLAN-ALMOTRIPTAN
MYLAN PHARMACEUTICALS ULC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of MYLAN-ALMOTRIPTAN in Canada?
A shortage of MYLAN-ALMOTRIPTAN 12.5MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated September 22, 2026), but it has not started yet.
Why is MYLAN-ALMOTRIPTAN not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will MYLAN-ALMOTRIPTAN be available again?
The manufacturer's estimated resolution date is February 9, 2027. This is an estimate and can change; follow this page to get an email when the status changes.
What this means
Does this mean the shortage is completely over everywhere?
It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.
What should I do?
If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.
DIN
02398443
Strength
12.5MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
ALMOTRIPTAN
Tier
Unrated
Last Updated
2026-09-23
Reason for Shortage
Disruption of the manufacture of the drug.
Past Reports for This Drug
MYLAN-ALMOTRIPTAN has 3 shortage/discontinuation reports on file — this is one of them.
Other Products from MYLAN PHARMACEUTICALS ULC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
500MG · DIN 02385473
333MG · DIN 02293269
40MG · DIN 02257963
10MG · DIN 02257955
DIN 02388138
DIN 02388146
50MG · DIN 02468549
2G · DIN 02407310
1G · DIN 02407302
12.5MG · DIN 02554631
100MG · DIN 02247244
25MG · DIN 02247243